Sarcomatrix Therapeutics Corp — Form C-W (Regulation Crowdfunding)

Sarcomatrix Therapeutics Corp filed a Form C-W (Regulation Crowdfunding) with the SEC on 2025-08-13.

Offering

Name	Role	Location
Michael Hitchcock	Director	King City, CA
David Craig	CEO	London, X0
David Craig	CEO, President, Chairman, Principal Accounting Officer	London, X0
Dean Burkin	Director	RENO, NV
Dean Josef Burkin	Board Member	RENO, NV
Ryan David Wuebbles	CSO	RENO, NV
Michael J.M. Hitchcock	Board Member	RENO, NV

Filed	Form	Target	Max
2025-08-13	C-U	$10K	$1.2M
2024-10-28	C	$10K	$1.2M
2024-08-13	C-U	$15K	$1.2M
2024-04-30	C	$15K	$1.2M